Larocca, Luigi Maria

Anemia in Hodgkin's Lymphoma: The Role of Interleukin-6 and Hepcidin

Hohaus, S., Massini, G., Giachelia, M., Vannata, B., Bozzoli, V., Cuccaro, A., D'Alo', F., Larocca, L. M., Raymakers, R. A. P., Swinkels, D. W., et al. (2010) · Journal of Clinical Oncology

Iron Metabolism and DisordersLymphoma Diagnosis and Treatment

Cited by 110

Is There a Role for IGF1R and c-MET Pathways in Resistance to Cetuximab in Metastatic Colorectal Cancer?

Inno, A., Di Salvatore, M., Cenci, T., Martini, M., Orlandi, A., Strippoli, A., Ferrara, A. M., Bagalà, C., Cassano, A., Larocca, L. M., et al. (2011) · Clinical Colorectal Cancer

Colorectal Cancer Treatments and StudiesLung Cancer Treatments and Mutations

Cited by 83

A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis

Martini, M., Teofili, L., Cenci, T., Giona, F., Torti, L., Rea, M., Foa, R., Leone, G., & Larocca, L. M. (2008) · Haematologica

Erythropoietin and Anemia TreatmentHemoglobinopathies and Related Disorders

Cited by 73

Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin

Tisi, M. C., Bozzoli, V., Giachelia, M., Massini, G., Ricerca, B. M., Maiolo, E., D’Alo’, F., Larocca, L. M., Piciocchi, A., Tjalsma, H., et al. (2014) · Leukemia & Lymphoma

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 59

Alterations of negative regulators of cytokine signalling in immunodeficiency‐related non‐Hodgkin lymphoma

Capello, D., Gloghini, A., Baldanzi, G., Martini, M., Deambrogi, C., Lucioni, M., Piranda, D., Famà, R., Graziani, A., Spina, M., et al. (2013) · Hematological Oncology

Lymphoma Diagnosis and TreatmentCytokine Signaling Pathways and Interactions

Cited by 15